Medical Marijuana: A Cure for Cancer?
Robert Melamede, Ph.D. – Biology Dept., UCCS, Cannabis Science Inc., Phoenix Tears Foundation – This article first appeared in TY Magazine Issue 28, 2011.
ABSTRACT
Every vertebrate, from the time of conception till the time of death, literally has all body systems homeostatically regulated by endocannabinoids (marijuana-like compounds produced by the body).
Illnesses are bio-chemical imbalances, failures of homeostasis.
By being alive, all organisms suffer from the common biochemical imbalances that underlie aging and all age-related illness, including autoimmune, cognitive, and cardiovascular diseases, as well as cancers.
Over 600 peer-reviewed articles show that numerous cancer types (lung, breast, prostate, glioma, thyroid, leukemia, lymphoma, basal-cell carcinoma, melanoma, etc.) are killed by cannabinoids in tissue culture and animal studies.
Furthermore, cannabinoids inhibit the bio-chemical pathways involved in metastasis and drug resistance.
The question that naturally arises is, “Why is a plant that inhibits aging, kills cancers, and whose activity is found in mother’s milk illegal?
Because federal and state governments have failed to implement marijuana policies that are reflective of modern scientific knowledge and thousands of years of medical history, the people have demanded and gained access to this miraculous medicine through direct vote with the initiative process.
In effect, marijuana clinical efforts are now in the hands of the people and the med-ical marijuana community.
This poster provides dramatic photographic evidence of cannabis extracts curing basal-cell carcinoma via its topical application.
HISTORY
This Australian woman grew up in Queensland, where the population suffers from the highest rate of skin can-cer in the world. Basal-cell carcinoma is the most com-mon form of cancer, with over 800,000 cases occurring each year in the US.
She had a number of surgeries to remove previous lesions diagnosed as basal-cell carcinomas.
After a new lesion appeared on her right cheek, alternative therapies that included the topical application of cannabis extracts were tried.
Cannabis extracts were applied daily until her surgeon stated that there was no need for surgery since the lesion on her cheek was gone.
However, a new lesion had appeared on her right nostril. The series of photos above documents the disappearance of the lesion on the nostril after ten days of self-administering topical cannabis extracts.
REFERENCES
Toth, B. I. et al. Endocannabinoids Modulate Human Epidermal Keratinocyte Proliferation and Survival via the Sequential Engagement of Cannabinoid Receptor-1 and Transient Receptor Potential Vanilloid-1. J Invest Dermatol. (2011).
Bilkei-Gorzo, A. et al. Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice. Neurobiol Aging. (2010).
Van Dross, R. T. Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes. Mol Carcinog. (2009).Biro, T.
Toth, B. I., Hasko, G., Paus, R. & Pacher, P. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportu-nities. Trends Pharmacol Sci. (2009).
Wilkinson, J. D. & Williamson, E. M. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential ther-apeutic value in the treatment of psoriasis. J Dermatol Sci 45, 87-92. (2007).
